miR-210 can attenuate cancer cell activity through downregulating E2F3, fibroblast growth factor receptor-like 1, homeobox protein Hox-A1, homeobox protein Hox-A9 and Max-binding protein [41,42,43]. The gene discussed is E2F3; the disease is cancer.